Log on / register
Feedback | Support | My details
Open AccessHighly AccessResearch article

Nasal septal perforation 1981–2005: Changes in etiology, gender and size

Liv Kari Døsen email and Rolf Haye email

Department of Otolaryngology, Rikshospitalet-Radiumhospitalet HF, University of Oslo, 0027 Oslo, Norway

author email corresponding author email

BMC Ear, Nose and Throat Disorders 2007, 7:1doi:10.1186/1472-6815-7-1

Published: 7 March 2007

Abstract

Background

Septal perforation is an uncommon but very bothersome illness and treatment is difficult particularly with large perforations. We wanted to establish the etiology and size of nasal septal perforations in an attempt to implement preventive measures.

Methods

This is an open, prospective clinical study of patients seen at our hospital from 1981 to 2005. The clinical data of size, gender and etiology have been recorded consecutively.

Results

One hundred and ninety seven patients (100 male, 97 female) were evaluated. Between 1981 and 1995 nasal septal perforation was caused by surgery in 40 of 102 (39.2 %). In the period 1995 to and inclusive of 2005 this percentage decreased as septal resection has been replaced by septo/septorhinoplasty. The latter was the cause for septal perforation in 14.7% in the last period. Nasal steroid and decongestive sprays have emerged as an important cause (28.4 %) during the last ten years particularly in females. In the first period 44 (43.1 %) and in the last 53 (55.7 %) patients were females. There was a noticeable reduction in the number of septal perforations 15 mm or larger in the last period.

Conclusion

Nasal steroid and decongestive sprays are now important causes for septal perforation. Information about this complication should be given with an advice to immediately report increasing and bothersome crusting and bleeding. Warning of the simultaneous use of nasal steroid and decongestive sprays should be addressed particularly to females. All patients with symptoms of septal perforation should promptly be referred to otolaryngologists for treatment.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.